Description:

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00989690

Link:

https://clinicaltrials.gov/show/NCT00989690

Keywords:
Versions (1) ▾
  1. 5/26/18
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

May 26, 2018

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lung Cancer NCT00989690

Eligibility Lung Cancer NCT00989690

  1. StudyEvent: Eligibility
    1. Eligibility Lung Cancer NCT00989690
Criteria